o-acetylation. - OmicsDI

Show results for

Unknown (386)
Proteomics (247)
Genomics (55)
Transcriptomics (47)
Other (5)
Metabolomics (3)

Organisms

Allexis (164)
Arabidopsis thaliana (164)
Callinectes sapidus (164)
Danio rerio (164)
Drosophila (164)
Drosophila melanogaster (164)
Entamoeba histolytica (164)
Entamoeba histolytica HM-1:IMSS-A (164)
Escherichia coli (164)
Homo sapiens (164)
Leishmania major strain Friedlin (164)
Homo sapiens (47)
Mus musculus (32)
cellular organisms (4)
Ogataea haglerorum (3)
Saccharomyces cerevisiae (2)
Drosophila melanogaster (2)
Bacillus subtilis subsp. subtilis str. 168 (2)
Ogataea polymorpha (2)
Oryza sativa (2)
Saccharomyces cerevisiae W303 (1)
Oryzias latipes (1)
Toxoplasma gondii (1)
Oryza sativa Japonica Group (1)
Escherichia coli (1)
Candida albicans (1)
Lactococcus cremoris subsp. cremoris MG1363 (1)
Bacillus subtilis (1)
Arabidopsis thaliana (1)
Rattus rattus (1)

Organisms

Homo sapiens (14)
Mus musculus (6)
Ogataea haglerorum (1)
Lactococcus cremoris subsp. cremoris MG1363 (1)
Triticum aestivum (1)
Oryzias latipes (1)
Bacillus subtilis subsp. subtilis str. 168 (1)
Arabidopsis thaliana (1)
Saccharomyces cerevisiae (1)

Repository

pride (164)
biostudies-arrayexpress (54)
MassIVE (52)
ENA (32)
jPOST (22)
geo (16)
iProX (6)
EGA (3)
GPMDB (2)
MetaboLights (2)
PanoramaPublic (2)
GNPS (1)
PAXDB (1)

Tissue

Cell culture (34)
Epithelial cell (15)
Brain (9)
Liver (8)
Permanent cell line cell (7)
Blood serum (6)
Hepatocyte (6)
Kidney (6)
Plant cell (6)
Leaf (5)
Fibroblast (4)
Dendritic cell (3)
HeLa cell (3)
Heart (3)
Primary cell (3)
Skin (3)
T cell (3)
Blood cell (2)
Blood plasma (2)
Cell suspension culture (2)
Cerebrospinal fluid (2)
Early embryonic cell (2)
Embryonic stem cell (2)
Seedling (2)
Stem cell (2)
Urine (2)
B cell (1)
B-cell chronic lymphocytic leukemia cell (1)
HEK-293FT cell (1)
JURKAT cell (1)

Disease

Alzheimer's disease (3)
Chronic kidney disease (3)
Chronic kidney disease (3)
Decreased fumarate hydratase activity (3)
Hepatocellular carcinoma (3)
Listeriosis (3)
Not Available (2)
Disease free (2)
Acute leukemia (1)
Brain cancer (1)
Breast cancer (1)
Cervix carcinoma (1)
Chronic lymphocytic leukemia (1)
Colon cancer (1)
Congenital heart disease (1)
Crohn's disease (1)
Global developmental delay (1)
Hyperphosphatemic familial tumoral calcinosis (1)
Infantile hypotonia with psychomotor retardation and characteristic facies-3 (1)
Liver cancer (1)
Lung adenocarcinoma (1)
Malignant neoplasm of ovary (1)
Melanoma (1)
Obesity (1)
Parkinson's disease (1)
Plasmodium falciparum malaria (1)
Renal cell carcinoma (1)
Renal clear cell carcinoma (1)
Rheumatoid arthritis (1)
Skin melanoma (1)

Technology Type

Mass Spectrometry (164)
Shotgun proteomics (104)
Bottom-up proteomics (29)
Gel-based experiment (24)
Affinity purification coupled with mass spectrometry proteomics (21)
Data-dependent acquisition (11)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
Mass spectrometry assay (2)
Data-independent acquisition (2)
Glycoproteomics (2)
HDMSE (2)
SRM/MRM (2)
SWATH MS (2)
Top-down proteomics (2)
Affinity proteomics (1)
DiaPASEF (1)

Instrument Platform

Orbitrap Fusion (20)
Q Exactive (7)
Orbitrap Fusion Lumos (6)
Orbitrap Eclipse (5)
LTQ Orbitrap (4)
LTQ Orbitrap Velos (3)
Instrument (2)
Q Exactive HF (2)
G2565BA DNA microarray scanner [Agilent] (1)
Illumina NovaSeq 6000 (1)
6560 Q-TOF LC/MS (1)
LTQ Velos (1)
Orbitrap Exploris 240 (1)
Orbitrap Fusion Lumos ETD (Thermo Scientific instrument model) (1)
Q Exactive HF-X (1)
Q Exactive Plus (1)
SYNAPT G2-Si (1)
Thermo Scientific Orbitrap Fusion Lumos EASY-ETD (1)
ThermoFisher LTQ FT-ICR Ultra (1)
ThermoFisher LTQ Linear Ion Trap (1)
TimsTOF Pro (1)
TimsTOF Pro 2 (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (55)
2023 (38)
2022 (29)
2024 (24)
2018 (22)
2021 (22)
2020 (18)
2026 (17)
2010 (14)
2016 (13)
2015 (13)
2013 (11)
2014 (9)
2019 (9)
2017 (7)
2011 (6)
2012 (4)
2009 (2)
2007 (2)
2008 (1)

UNIPROT ID/AC

5811.TGME49_004050 (1)
5811.TGME49_005250 (1)
5811.TGME49_027920 (1)
5811.TGME49_044150 (1)
5811.TGME49_054560 (1)
5811.TGME49_094800 (1)
5811.TGME49_102050 (1)
5811.TGME49_119870 (1)
5811.TGME49_119920 (1)
A0A0F7UMP6_TOXGV (1)
A0A0F7UN03_TOXGV (1)
A0A0F7UNS9_TOXGV (1)
A0A0F7UNU4_TOXGV (1)
A0A0F7URF8_TOXGV (1)
A0A0F7US18_TOXGV (1)
A0A0F7USK4_TOXGV (1)
A0A0F7USU7_TOXGV (1)
A0A0F7UTC9_TOXGV (1)
A0A0F7UTQ6_TOXGV (1)
A0A0F7UTS9_TOXGV (1)
A0A0F7UU04_TOXGV (1)
A0A0F7UU07_TOXGV (1)
A0A0F7UUM4_TOXGV (1)
A0A0F7UVN4_TOXGV (1)
A0A0F7UWM4_TOXGV (1)
A0A0F7UXU1_TOXGV (1)
A0A0F7UXX2_TOXGV (1)
A0A0F7UY31_TOXGV (1)
A0A0F7UYG5_TOXGV (1)
A0A0F7UZH2_TOXGV (1)

CHEBI ID

CHEBI:38265 (1)
CHEBI:71494 (1)
CHEBI:64235 (1)
CHEBI:64238 (1)
CHEBI:64236 (1)
CHEBI:64239 (1)
CHEBI:4685 (1)
CHEBI:17447 (1)

Metabolite Name

N-(3-bromophenyl)-2-[4-(morpholin-4-ylcarbonyl)-2-oxohydroquinolyl]acetamide (1)
1,2,4-Triazin-5(2H)-one, 6-(1,1-dimethylethyl)-3-(methylthio)- (1)
2-Hydroxy-4-Methoxychalcone (1)
N,N-Diethyl-4-Hydroxybenzamide (1)
P-Toluenesulfonamide (1)
2-(methylethylidene)butanedioic acid (1)
2-(3-(8-hydroxyoctyl)phenoxy)-2-methylpropanoic acid (1)
2-(4-methyl-6-(2-naphthyloxy)pyrimidin-2-ylthio)-1-phenylethan-1-one (1)
PS(18:1/18:0) (1)
2-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-pyrazol-5-yl)-4-ethyl-5-methoxyphenol (1)
3,4-dimethyl-9-phenyl-7H-furo[2,3-f]chromen-7-one (1)
12-Hydroxy-6-Epi-Albrassitriol (1)
Ethyl 2-[2-(1,3,7-trimethyl-2,6-dioxo-1,3,7-trihydropurin-8-ylthio)benzimidazo lyl]acetate (1)
[4-(difluoromethoxy)-3-ethoxyphenyl]-N-(1-methylpyrazol-3-yl)carboxamide (1)
2-{4-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-enyl]phenoxy}acetamide (1)
Sissotrine (1)
Methyl 2-[(5,6,7-trimethoxy-3-oxohydroisobenzofuran-4-yl)methylthio]benzoate (1)
N-(2-chlorophenyl)-2-[2-oxo-4-(piperidylcarbonyl)hydroquinolyl]acetamide (1)
NA-135 (1)
1,3,6-Trihydroxy-2-(3-methylbut-2-enyl)xanthen-9-one (1)
7-(1,6-dihydroxy-3-methyl-5-(methylethyl)-8-{[(2-methylphenyl)amino]methylene} -7-oxo(2-naphthyl))-3,8-dihydroxy-6-methyl-4-(methylethyl)-1-{[(2-methylphenyl )amino]methylene}naphthalen-2-one (1)
Phenylmethyl 1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]pyrrolidine-2-carboxylate (1)
7-Benzofurancarboxylic acid, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-6-(2-phenylethyl)- (1)
3-ethyl-4-hydroxy-1-benzylhydroquinolin-2-one (1)
Kaurenic acid (1)
(2Z)-2-benzoxazol-2-yl-3-(4-hydroxy-3-methoxyphenyl)-1-(4-methylphenyl)prop-2- en-1-one (1)
2-[4-(N,N-diethylcarbamoyl)-2-oxohydroquinolyl]-N-(2,4-difluorophenyl)acetamid e (1)
Pantothenic acid (Not validated) (1)
2H-benzo[3,4-d]1,3-dioxolen-5-yl-N-(4,5,6,7-tetrahydrobenzothiazol-2-yl)carbox amide (1)
1H-indole-3-carboxamide (1)

First Public Date

2026 (8)
2014 (5)
2025 (4)
2023 (4)
2022 (4)
2024 (3)
2019 (2)
2018 (2)

Modification

+3amu) (2)
-17.026549 (2)
15.994915 (2)
42.010565 (2)
32.056407 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
45.029395 (1)
6.020129 (1)
N6 (1)

Study type

Transcription profiling by array (25)
ChIP-seq (13)
RNA-seq of coding RNA (7)
ChIP-chip by tiling array (3)
ChIP-chip by array (2)
Comparative genomic hybridization by array (1)
Other (1)
Methylation profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (40)
2017 (39)
2021 (34)
2020 (30)
2014 (27)
2023 (27)
2025 (25)
2016 (24)
2011 (23)
2018 (23)
2015 (22)
2012 (19)
2010 (19)
2013 (16)
2019 (16)
2024 (13)
2009 (8)
2008 (7)
2007 (6)
2026 (6)
2006 (3)
2005 (3)
2004 (3)
1999 (2)
1997 (2)
2003 (1)
2001 (1)
1998 (1)

Lab affiliation

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia (5)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne 3000, Australia (4)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (3)
Carnegie Mass Spectrometry Facility (2)
Department of Biology – Cellular Proteostasis and Mass Spectrometry, University of Konstanz (2)
Department of Chemistry, Stanford University (2)
Institut Pasteur Unité des Interactions Bactéries-Cellules, Inserm U604, INRA USC2020 25 rue du Dr. Roux 75015 Paris France (2)
James Cook University (2)
School of Life Science, Fudan University (2)
1 Department of Genetics, Harvard Medical School, Boston, MA 02115 (1)
1 Department of Medicine - Western Health, The University of Melbourne, Melbourne, Australia The Australian Institute for Musculoskeletal Science (AIMSS), Western Health, Victoria University and The University of Melbourne, Melbourne, Australia 3 Institute for Health and Sport, Victoria University, Melbourne, Australia (1)
1 Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria; 2 Department of Neuroscience, Karolinska Institutet, Retzius väg 8, SE-17177 Stockholm, Sweden (1)
1.Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China (1)
Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Marseille, France (1)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (1)
Assistant Professor,Department of Civil, Structural and Environmental Engineering, Ye lab, University at Buffalo(SUNY), USA (1)
Augusta University Medical College of Georgia (1)
Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Beijing Key Laboratory of DNA Damage Response and College of Life Science, Capital Normal University, Beijing 100048, China (1)
Beijing Tongren Hospital, Capital Medical University (1)
Ben Gurion University (1)
Bioanalytik (1)
Biochemistry (1)
Biological Chemistry Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States (1)
Biomedicinska inst (1)
Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, Copenhagen 2200, Denmark (1)
CBMN UMR5248 CNRS-Univ. Bordeaux (1)
CECAD Research Center, University of Cologne, Joseph-Stelzmann-Str 26, 50931 Cologne, Germany (1)
CNRS, INSERM, Univ. Lille, CHU Lille, Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille, 59000 Lille, France (1)
Carnegie Mass Spec Facility (1)

Previous page
1 / 75
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 75
Next page

Sort by:

Relevance

Page size

Human NXPE1 mediates variation in sialic acid O-acetylation in Colon Tissue

Sialylation, and its modifications, have important consequences for development, differentiation and immune system regulation in nearly all human tissues. An accounting of all the genes responsible for modifying sialic acids is incomplete, with only one pathway for O-acetylation being well-defined i...

EGAS00001007704 | EGA

Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 is Biased Towards Proteins Involved in Growth, Virulence and Antimicrobial Resistance

Protein acetylation is one of the post-translational modifications (PTMs) involved in regulating a myriad of cellular processes in bacteria. Increasing evidence demonstrates that lysine acetylation is involved in Mycobacterium tuberculosis (Mtb) virulence and pathogenesis. However, previous reports ...

ORGANISM(S): Mycobacterium tuberculosis H37Rv

2018-05-02 | PXD006630 | Pride